Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

178 III. SUBSTANCES OF ABUSEChopra, G. S., & Smith, J. W. (1974). Psychotic reactions following cannabis use inEast Indians. Arch Gen Psychiatry, 30, 24–27.Cohen, R. (1998). The love drug: Marching to the beat of Ecstasy. Binghamton, NY:Hayworth Press.Cooper, M. (1996, January 28). “Special K”: Rough catnip for clubgoers. New YorkTimes, p. A-6.Cotman, C. W., & Monaghan, D. T. (1987). Chemistry and anatomy of excitatoryamino acid systems. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generationof progress (pp. 194–210). New York: Raven Press.Creighton, F., Black, D., & Hyde, C. (1991). Ecstasy psychosis and flashbacks. Br J Psychiatry,159, 713–715.Crider, R. A. (1986). Phencyclidine: Changing abuse patterns. In D. H. Clouet (Ed.),Phencyclidine: An update (pp. 163–173). Rockville, MD: U.S. Department ofHealth and Human Services.Curran, H. V., & Monaghan, L. (2001). In and out of the K-hole: A comparison of theacute and residual effects of ketamine in frequent and infrequent ketamine users.Addiction, 96, 749–760.Deas, D., Gerding, L., & Hazy, J. (2000). Marijuana and panic disorder. J Am Acad ChildAdolesc Psychiatry, 39, 1467.Delgarno, P. J., & Shewan, D. (1996). Illicit use of ketamine in Scotland. J PsychoactiveDrugs, 28, 191–199.Demirkiran, M., Jankovic, J., & Dean, J. (1996). Ecstasy intoxication: An overlapbetween serotonin syndrome and neuroleptic malignant syndrome. Clin Neuropharmacol,19, 157–164.Dotson, J., Ackerman, D., & West, L. (1995). Ketamine abuse. J Drug Issues, 25, 751–757.Eisner, B. (1986). Ecstasy: The MDMA story. Boston: Little, Brown.Eisner, B. (1993). Ecstasy: The MDMA story (2nd ed.). Berkeley, CA: Ronin.Feeney D. (1976). Marijuana use among epileptics. JAMA, 235, 1105.Fox, H. C., Parrott, A. C., & Turner, J. J. (2001). Ecstasy use: Cognitive deficits relatedto dosage rather than self reported problematic use of the drug. J Psychopharmacol,15, 273–281.Fort Dodge Laboratories. (1997). Ketaset [Package insert]. Fort Dodge, IA: Author.Gallimberti, L., Canton, G., Gentile, N., Ferri, M., Cibin, M., Ferrara, S. D., et al.(1989). Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.Lancet, 30, 787–789.Galloway, G. P., Frederick, S. L., Staggers, F. E., Jr., Gonzales, M., Stalcup, S. A., &Smith, D. E. (1997). Gamma-hydroxybutyrate: An emerging drug of abuse thatcauses physical dependence. Addiction, 92, 89–96.Garfield, J. M., Garfield, F. B., Stone, J. G., Hopkins, D., & Johns, L. A. (1994). A comparisonof psychologic responses to ketamine and thiopental-nitrous oxide-halothaneanesthesia. Anesthesiology, 36, 329–338.Gay Men’s Health Crisis (McDowell, D., Consultant). (1997). Drugs in partyland [Brochure].New York: GMHC Press.Graeme, K. A. (2000). New drugs of abuse. Emerg Med Clin North Am, 18(4), 625–636.Green, A., Cross, A., & Goodwin, G. (1995). Review of pharmacology and clinicalpharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”).Psychopharmacology, 119, 247–260.